Development and Implementation Model of Home Based Cardiac Rehabilitation With Family Empowerment Approach in Patient With ACS (HBCR in ACS) (HBCR in ACS)

June 11, 2025 updated by: Eva Marti,Ns.,M.Kep, Gadjah Mada University

The aim of this clinical trial is to determine whether home-based cardiac rehabilitation with a family empowerment approach can help acute coronary syndrome patients recover. The main questions to be answered are:

- Does home-based cardiac rehabilitation with a family approach effective in patients with acute coronary syndrome to improve health-related quality of life and peak Vo2? Researchers will compare with usual care to see if home-based cardiac rehabilitation with a family approach is more effective for improving health-related quality of life and peak Vo2 in ACS patients.

Patient inclusion criteria

  1. Patients with acute coronary syndrome who had undergone hospitalization, with a minimum home care time of 3 months and a maximum of 1 year, calculated from the day of discharge from the hospital until the time of the interview.
  2. Aged 18-65 years old, participants were selected with age variations representing young adults, adults and the elderly.
  3. Patients with first experience of SCA, participants were selected whether they had undergone PCI or not.
  4. Patients living with family and family involved in the patient care process.

  5. Physical condition allows for interviews. physical condition is evidenced by examination of stable vital signs (diastolic BP

    >90, systolic <150 mmhg; N: 60-100x/min; S: 36-380c, no pain). Psychological condition does not show symptoms of depression as measured by the Patient Health Questionnaire-9 instrument.

  6. Willing to participate in the study.

Participants will:

For 12 weeks

  1. Perform walking exercises as prescribed
  2. Implement diets and stress management according to the module
  3. Quit smoking
  4. Medication compliance
  5. visit the clinic to see a cardiologist, undergo a 6-minute walk test

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

How to enroll patients as research subjects Inpatients

  1. The research team determines SKA patients who fit the study criteria
  2. The room nurse helps explain to the patient to be involved in the study, explaining the purpose, benefits, procedures of the study and possible risks
  3. The room nurse will ask the patients willingness to be involved in the study.
  4. The patient signs the Informed consent
  5. The nurse explains the interventions that will be provided after informed consent during the first hospital visit (details of the interventions are in the next section).
  6. The nurse will give the prospective research subject identification card to the family and convey it to the outpatient clinic nurse.

Outpatients

  1. The research team draws data from medical records and determines appropriate outpatients. With criteria
  2. The research team gave a list of patients who could be used as research subjects to the outpatient nurse on duty
  3. The nurse will help explain to the patient to be involved in the study, explaining the purpose, benefits, procedures of the study and the risks that may occur
  4. The room nurse will ask for the patients willingness to be involved in the study.
  5. The patient signs the Informed consent

Intervention HBCR with FCEM approach

  1. Baseline measurement and entry test stage
  2. At this stage, peak VO2 measurement is taken, measured based on 6MWT travel time. The results of the 6-minute walk test will be used to determine the intensity of home exercise to be performed. The research subjects will undergo ECG examination before and after the 6MWT to ensure the following
  3. Patients and families will receive the HBCR module, which consists of a guidebook and educational video at the beginning of the counselling education session.
  4. Patients and families receive a video by a cardiologist explaining. disease and treatment, a video by a psychologist on stress management, a dietician on food management, aiming to maintain weight and blood sugar levels and a video on smoking cessation guidance by a smoking counsellor.

  5. Family-centered empowerment education stage

    • Explain the threat of ACS, signs and symptoms, clinical manifestations, complications, treatment and follow-up care, risk factor control, and the role of the family in home-based cardiac rehabilitation (all families in the intervention group).
    • Patients and families are guided by 1 facilitator. In the group, an intervention to increase self-efficacy was conducted by exploring problems that might arise in advanced care, and then exploring joint solutions to these problems.
    • Interventions to improve self-esteem and family participation were conducted. Family members were educated based on the distributed module on controlling the risk of SCA patients in cardiac rehabilitation, practiced how to accompany and monitor patients in cardiac rehabilitation Given positive reinforcement and feedback. The group also ensures the family's correct understanding in managing cardiac rehabilitation at home through a question and answer session.
    • The facilitator evaluates the process and results of the stages that have been carried out to family members.

  6. 12 weeks Home-based Cardiac Rehabilitation

    1. The hbcr session is 12 weeks, the patient will be seen by the cardiologist at weeks 1, 6, 12. During the 12-week intervention process, the cardiologist in charge of the patient is the same cardiologist who performed the risk assessment examination on the patient, determining the activity based on the first 6MWT test performed by the patient. During the intervention process, the facilitating nurse will report to the cardiologist in charge if there is any deterioration in the patiens condition, in terms of vital signs and activities.
    2. Smoking, diet and stress management counseling was conducted at the beginning of the session, and follow-up by the nurse every 2 weeks in month 1, and every 4 weeks in the following month (in the form of follow-up per video call/home visit). Visit every 4 weeks to the cardiologist
    3. Physical exercise is done 3 times a week, 1 session of 30-40 minutes. Patients can choose from jogging, cycling, weight lifting or aerobic exercise. Each exercise session consists of 5 minutes of warm-up, 30 minutes of core exercise and 5 minutes of cool-down. Patients and families are given a video on the direction of the physical exercise to be performed. Each exercise is accompanied by the family, to monitor the patients HR, complaints during the exercise session.
    4. The family reports HR and complaints during exercise, immediately after the exercise is performed
    5. The family reports daily diet, exercise frequency, complaints on the form provided.

During the intervention period, the family reported daily diets, medication adherence and exercise activities as well as HR during exercise through a daily google form that would be monitored by the facilitating nurse.

The control group will receive education on the components of medication adherence, exercise, smoking behaviour, diet, and stress management for 1 session.

Forms of protection for patients and families:

  1. Informed consent is given in detail, clearly and easily understood by patients and families.
  2. Confidentiality of patient and family data
  3. Patients and families have the right to resign during the research process.
  4. Families are trained and enabled to provide home-based cardiac rehabilitation assistance to patients before the intervention is carried out.
  5. The activity plan given to patients is in accordance with their abilities, as measured by the 6MWT test. Patients who participated were patients with mild and moderate categories.
  6. There is one cardiologist who is in charge of the intervention and a nurse facilitator who will conduct daily monitoring through g forms, monitoring every two weeks through video calls or home visits. Nurse facilitators have previously been trained.
  7. There is a prepared flow in case of an emergency situation, by coordinating with the nearest health care centre to the patient.

Study Type

Interventional

Enrollment (Estimated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Indonesia
      • Yogyakarta, Indonesia, 55281
        • Recruiting
        • RSUP dr Sardjito
        • Contact:
        • Principal Investigator:
          • Eva Marti
    • Yogyakarta
      • Sleman, Yogyakarta, Indonesia
        • Not yet recruiting
        • Gadjah Mada University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Patients with acute coronary syndrome who have undergone hospitalization, with a minimum home care time of 3 months and a maximum of 1 year, calculated from the day of discharge from the hospital until the time of interview.
  2. Aged 18-65 years, participants were selected with age variations representing young adults, adults and the elderly.
  3. Patients with first experience of SCA, participants were selected whether they had undergone PCI or not.
  4. Patients living with family and family involved in the patient care process.

  5. Physical condition allows for interviews. physical condition is evidenced by examination of stable vital signs (diastolic BP

    >90, systolic <150 mmhg; N: 60-100x/min; S: 36-380c, no pain). Psychological condition does not show symptoms of depression as measured by the Patient Health Questionnaire-9 instrument.

  6. Willing to participate in the study.

Exclusion Criteria:

  • Patients with comorbidities that require routine medication such as Diabetes Mellitus, hypertension, renal failure

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental arm
Experimental arm receive 12 week home based cardiac rehabilitation include physical exercise, dietary management, smoking cessation and stress management
Behavioral: Home based cardiac rehabilitation
12 week home based cardiac rehabilitation include Physical exercise, dietary management, smoking cessation and stress management
No Intervention: control arm
Control arm receive usually care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
health related quality of life
Time Frame: From enrollment to the end of treatment at 12 weeks
Individuals perception of their level of health, current condition which includes physical, psychological and social dimensions, will be measured with MacNew Heart questionnaire. scored from 1 (low HRQOL) to 7 (high HRQOL). The maximum possible score in any domain is 7
From enrollment to the end of treatment at 12 weeks
peak Vo2
Time Frame: From enrollment to the end of treatment at 12 weeks
peak vo2 achieved based on 6minute walk test, in ml/kg/min
From enrollment to the end of treatment at 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Gadjah Mada University

Investigators

  • Study Director: Anggoro Budi Hartopo, PhD, Gadjah Mada University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2025

Primary Completion (Actual)

June 10, 2025

Study Completion (Estimated)

September 30, 2025

Study Registration Dates

First Submitted

October 1, 2024

First Submitted That Met QC Criteria

October 1, 2024

First Posted (Actual)

October 3, 2024

Study Record Updates

Last Update Posted (Actual)

June 15, 2025

Last Update Submitted That Met QC Criteria

June 11, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Eva marti 1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Coronary Syndromes

Clinical Trials on Home based cardiac rehabilitation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe